Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
Identifieur interne : 001528 ( Main/Exploration ); précédent : 001527; suivant : 001529Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
Auteurs : S. Papapetropoulos [États-Unis] ; A. Lieberman [États-Unis] ; J. Gonzalez [États-Unis] ; D. C. Mash [États-Unis]Source :
- Acta Neurologica Scandinavica [ 0001-6314 ] ; 2005-06.
English descriptors
Abstract
Objectives – Patients with clinical and pathological diagnosis of Parkinson's disease (PD) may, at death, also be found to have the pathological changes of Alzheimer's disease (AD). With this study we aim to determine the influence of AD pathology on the clinical phenotype of PD. Methods – We studied 64 patients who donated their brains to the University of Miami Brain Endowment BankTM and fulfilled the clinical and pathological criteria for PD. For the evaluation of AD pathology we used the CERAD criteria. Dementia was diagnosed, in life, also using standard criteria. Case histories were abstracted and reviewed by one investigator (SP) who then made comparisons between patients. Results – Patients with AD pathology (PD–AD) were older both at the time of diagnosis and death. The presence of AD pathology did not seem to influence disease duration in our cohort of PD patients. As expected there was a clear relation between AD pathology and dementia but not all PD–AD patients were demented. Psychosis and depression were also found to be more prevalent in the PD–AD patients. In the comparison between demented and non‐demented PD–AD patients dementia was more likely to appear in patients with PD and definite criteria for AD. Conclusion – Apart from dementia AD pathology seems to be associated with a number of other clinical characteristics of PD.
Url:
DOI: 10.1111/j.1600-0404.2005.00411.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?</title><author><name sortKey="Papapetropoulos, S" sort="Papapetropoulos, S" uniqKey="Papapetropoulos S" first="S." last="Papapetropoulos">S. Papapetropoulos</name></author><author><name sortKey="Lieberman, A" sort="Lieberman, A" uniqKey="Lieberman A" first="A." last="Lieberman">A. Lieberman</name></author><author><name sortKey="Gonzalez, J" sort="Gonzalez, J" uniqKey="Gonzalez J" first="J." last="Gonzalez">J. Gonzalez</name></author><author><name sortKey="Mash, D C" sort="Mash, D C" uniqKey="Mash D" first="D. C." last="Mash">D. C. Mash</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:0FD63F89D24DADE7DC9BBB31FA0D5FFBB07E52F8</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1111/j.1600-0404.2005.00411.x</idno><idno type="url">https://api.istex.fr/document/0FD63F89D24DADE7DC9BBB31FA0D5FFBB07E52F8/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000708</idno><idno type="wicri:Area/Main/Curation">000620</idno><idno type="wicri:Area/Main/Exploration">001528</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?</title><author><name sortKey="Papapetropoulos, S" sort="Papapetropoulos, S" uniqKey="Papapetropoulos S" first="S." last="Papapetropoulos">S. Papapetropoulos</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, School of Medicine, University of Miami, Miami, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Lieberman, A" sort="Lieberman, A" uniqKey="Lieberman A" first="A." last="Lieberman">A. Lieberman</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, School of Medicine, University of Miami, Miami, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Parkinson Foundation (NPF), Miami, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Gonzalez, J" sort="Gonzalez, J" uniqKey="Gonzalez J" first="J." last="Gonzalez">J. Gonzalez</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, School of Medicine, University of Miami, Miami, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Mash, D C" sort="Mash, D C" uniqKey="Mash D" first="D. C." last="Mash">D. C. Mash</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, School of Medicine, University of Miami, Miami, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Neurologica Scandinavica</title><idno type="ISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><imprint><publisher>Munksgaard International Publishers</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2005-06">2005-06</date><biblScope unit="volume">111</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="353">353</biblScope><biblScope unit="page" to="359">359</biblScope></imprint><idno type="ISSN">0001-6314</idno></series><idno type="istex">0FD63F89D24DADE7DC9BBB31FA0D5FFBB07E52F8</idno><idno type="DOI">10.1111/j.1600-0404.2005.00411.x</idno><idno type="ArticleID">ANE411</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-6314</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alzheimer's disease</term><term>Parkinson's disease</term><term>clinical phenotype</term><term>neuropathology</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objectives – Patients with clinical and pathological diagnosis of Parkinson's disease (PD) may, at death, also be found to have the pathological changes of Alzheimer's disease (AD). With this study we aim to determine the influence of AD pathology on the clinical phenotype of PD. Methods – We studied 64 patients who donated their brains to the University of Miami Brain Endowment BankTM and fulfilled the clinical and pathological criteria for PD. For the evaluation of AD pathology we used the CERAD criteria. Dementia was diagnosed, in life, also using standard criteria. Case histories were abstracted and reviewed by one investigator (SP) who then made comparisons between patients. Results – Patients with AD pathology (PD–AD) were older both at the time of diagnosis and death. The presence of AD pathology did not seem to influence disease duration in our cohort of PD patients. As expected there was a clear relation between AD pathology and dementia but not all PD–AD patients were demented. Psychosis and depression were also found to be more prevalent in the PD–AD patients. In the comparison between demented and non‐demented PD–AD patients dementia was more likely to appear in patients with PD and definite criteria for AD. Conclusion – Apart from dementia AD pathology seems to be associated with a number of other clinical characteristics of PD.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Floride</li></region></list><tree><country name="États-Unis"><region name="Floride"><name sortKey="Papapetropoulos, S" sort="Papapetropoulos, S" uniqKey="Papapetropoulos S" first="S." last="Papapetropoulos">S. Papapetropoulos</name></region><name sortKey="Gonzalez, J" sort="Gonzalez, J" uniqKey="Gonzalez J" first="J." last="Gonzalez">J. Gonzalez</name><name sortKey="Lieberman, A" sort="Lieberman, A" uniqKey="Lieberman A" first="A." last="Lieberman">A. Lieberman</name><name sortKey="Lieberman, A" sort="Lieberman, A" uniqKey="Lieberman A" first="A." last="Lieberman">A. Lieberman</name><name sortKey="Mash, D C" sort="Mash, D C" uniqKey="Mash D" first="D. C." last="Mash">D. C. Mash</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001528 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001528 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:0FD63F89D24DADE7DC9BBB31FA0D5FFBB07E52F8
|texte= Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
}}
| This area was generated with Dilib version V0.6.23. |  |